In Renal Cell Carcinoma, Exceptional Responders to Anti-PD1 Therapy Exhibit Distinct Profiles

In Renal Cell Carcinoma, Exceptional Responders to Anti-PD1 Therapy Exhibit Distinct Profiles. November 7, 2015—Miami, Florida—In renal cell carcinoma, exceptional responders and primary refractory patients display distinct pathologic, genomic, and RNA expression profiles  The rest of the abstract is a bit heady so here is the Nova style- We are beginning to dissect out the DNA, the RNA made from it – which means the code, the blueprint for every single thing in a cancer cell and uncover what changes in the blueprint make for a patient who responds exceptionally beyond the odds and a patient who is resistant to therapy from the start Think of the implications if we can get to this point in all cancers as part of their diagnosis and staging. They only had a handful of patients but the difference was startling and significantly different and Renal cell is one of the hardest cancers to beat

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s